Cuu Long Pharmaceutical JSC (HOSE:DCL)
38,900
+300 (0.78%)
At close: Aug 13, 2026
HOSE:DCL Revenue
Cuu Long Pharmaceutical JSC had revenue of 285.34B VND in the quarter ending June 30, 2026, a decrease of -11.72%. This brings the company's revenue in the last twelve months to 1.27T, down -10.03% year-over-year. In the year 2025, Cuu Long Pharmaceutical JSC had annual revenue of 1.32T with 1.13% growth.
Revenue (ttm)
1.27T
Revenue Growth
-10.03%
P/S Ratio
2.24
Revenue / Employee
1.34B
Employees
948
Market Cap
2.84T
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.32T | 14.79B | 1.13% |
| Dec 31, 2024 | 1.31T | 162.85B | 14.24% |
| Dec 31, 2023 | 1.14T | 128.26B | 12.63% |
| Dec 31, 2022 | 1.02T | 312.05B | 44.35% |
| Dec 31, 2021 | 703.63B | 32.39B | 4.83% |
| Jan 1, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DHG Pharmaceutical JSC | 5.45T |
| Traphaco JSC | 2.77T |
| Ha Tay Pharmaceutical JSC | 2.48T |
| Imexpharm | 2.32T |
| Domesco Medical Import - Export Joint-Stock | 2.13T |
| Binh Dinh Pharmaceutical and Medical Equipment JSC | 1.87T |
| OPC Pharmaceutical JSC | 1.15T |
| Vidipha Central Pharmaceutical JSC | 979.05B |